James (Josh) Wilson Faruqi & Faruqi, LLP
Faruqi & Faruqi Reminds Verve Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 - VERV
13 sept. 2024 09h42 HE | Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Verve To Contact Him Directly To Discuss Their Options If...
James (Josh) Wilson Faruqi & Faruqi, LLP
Faruqi & Faruqi Reminds Sage Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 - SAGE
13 sept. 2024 09h40 HE | Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Sage To Contact Him Directly To Discuss Their Options If...
James (Josh) Wilson Faruqi & Faruqi, LLP
Faruqi & Faruqi Reminds Vicor Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 23, 2024 - VICR
13 sept. 2024 09h39 HE | Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Vicor To Contact Him Directly To Discuss Their Options If...
James (Josh) Wilson Faruqi & Faruqi, LLP
Faruqi & Faruqi Reminds Lifecore Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 27, 2024 - LFCR
13 sept. 2024 09h37 HE | Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Lifecore To Contact Him Directly To Discuss Their Options If...
James (Josh) Wilson Faruqi & Faruqi, LLP
Faruqi & Faruqi Reminds Extreme Networks Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 15, 2024 - EXTR
13 sept. 2024 09h36 HE | Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Extreme Networks To Contact Him Directly To Discuss Their...
Brent Ness, CEO and Director of Aclarion, Inc.
PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology
13 sept. 2024 08h30 HE | PRISM MarketView
PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology
Screenshot 2023-10-16 at 4.30.56 PM.png
34/2024・Trifork Group AG – Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them
13 sept. 2024 06h16 HE | Trifork Group AG
  Company announcement no. 34 / 2024 Schindellegi, Switzerland – 13 September 2024 Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated...
Yahoo Logo 1029x579.jpg
BIO-key International Enters into $1.9 Million Warrant Inducement
12 sept. 2024 13h18 HE | BIO-key International, Inc.
BIO-key International (Nasdaq: BKYI) Enters into $1.9 Million Warrant Inducement
AMPG Logo.png
AmpliTech Group’s AGTGSS Division Receives Initial Order For Its Midband 5G Radio Networks From Historic University of Edinburgh UK
12 sept. 2024 08h30 HE | AmpliTech Group, Inc.
AmpliTech Group’s AGTGSS Division Receives Initial Order For Its Midband 5G Radio Networks From Historic University of Edinburgh, UK
XERIANT NEW LOGO FLAT BLACK-2x1.png
Xeriant NEXBOARD™ Update: Finalizing Testing and Setting Up Production
12 sept. 2024 08h05 HE | Xeriant, Inc.
Xeriant (OTCQB: XERI) preparing NEXBOARD™ for certification testing and initial commercial production.